期刊文献+

miRNA-192在骨肉瘤临床样本中的表达及与各临床要素之间关系的相关研究

Research on Expression of miRNA-192 in Human Osteosarcoma and the Relationship between It and Clinicopathological Features
原文传递
导出
摘要 目的:观察miRNA-192在骨肉瘤中与各临床要素之间的关联,分析其与骨肉瘤患者生存情况之间的关系,为研究miRNA-192在骨肉瘤中的作用及可能的临床应用提供理论依据。方法:选取50例骨肉瘤新鲜样本组织及瘤旁组织,使用荧光RT-PCR的方法对样本中的miRNA-192的含量进行检测,结合详实的随访资料,分析miRNA-192与性别、年龄等临床要素之间的关系。通过生存分析的方法,分析miRNA-192与患者生存情况之间的关系。结果:miRNA-192与患者的年龄,肿瘤大小,分期,生存时间等有明显的统计学关联(P<0.05),包括年龄(P=0.028),临床分期(P=0.007),远端转移(P=0.013)和生存率(P=0.001)。结论:在临床样本中,miRNA-192与患者的多项临床要素有显著性关联,包括年龄,临床分期,远端转移和生存率,为接下来关于miRNA-192在骨肉瘤中的各项研究,特别是作为生物标记信号的临床应用奠定了良好的实验基础。 Objective: To explore and describe the relationship of miRNA-192 function and clinicopathological features in human osteosarcoma and analyze the relationship between miRNA-192 and mortality, which support some theoretical basis for osteosarcoma treatment and element experience for further research. Methods: Real-time quantitative PCR analysis were used in 50 clinical osteosarcoma samples which were followed up. Then the relationship of miRNA-192 function and clinicopathological features(like sex,age) in human osteosarcoma were explored. Results: We found that there were statistically significant relationships between miRNA-192 expression and some clinicopathological features of osteosarcoma, including age(P = 0.028), clinical stage(P = 0.007), distant metastasis(P = 0.013) and patient mortality(P=0.001). Conclusion: In clinical specimens, miRNA-192 expression levels were correlated with some clinicopathological features of osteosarcoma, including age, clinical stage, distant metastasis and patient mortality, which provided the theoretical basis for the next study especially the biological therapy of miRNA-192 in the osteosarcoma.
出处 《现代生物医学进展》 CAS 2016年第18期3504-3507,共4页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(81201633) 济南军区总医院院长基金项目(2015ZX01)
关键词 miRNA-192 生存 转移 骨肉瘤 MicroRNA-192 Mortality Metastasis Osteosarcoma
  • 相关文献

参考文献18

  • 1Janeway KA, Grier HE. Sequelae of osteosarcoma medical therapy: A review of rare acute toxicities and late effects[J]. The lancet oncology, 2010, 11(7): 670-678.
  • 2Osborne TS, Khanna C. A review of the association between osteosarcoma metastasis and protein translation [J]. Journal of comparative pathology, 2012, 146(2-3): 132-142.
  • 3He JP, Hao Y, Wang XL, et al. Review of the molecular pathogenesis of osteosarcoma [J]. Asian Pacific journal of cancer prevention: APJCP, 2014, 15(15): 5967-5976.
  • 4Broadhead ML, Clark JC, Choong PF, et al. Making gene therapy for osteosareoma a reality [J]. Expert review ofanticancer therapy, 2010, 10(4): 477-480.
  • 5Cheng Q, Yi B, Wang A, et al. Exploring and exploiting the fundamental role of microRNAs in tumor pathogenesis [J]. OncoTargets and therapy, 2013, 6(4): 1675-1684.
  • 6Tian Q, Jia J, Ling S, et al. A causal role for circulating mir-34b in osteosarcoma [J]. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2014, 40(1): 67-72.
  • 7韩康,赵廷宝,卞娜,蔡成魁,颜世举,王鑫,肖春,沙浩,董川,杨彤涛,周勇,马保安.利用慢病毒载体观察microRNA-194对人骨肉瘤细胞系U2-OS生物学特性的影响[J].现代生物医学进展,2014,14(23):4401-4405. 被引量:3
  • 8Hammond SM. An overview of micromas[J]. Advanced drug delivery reviews, 2015, 8(7): 3-14.
  • 9Krupa A, Jenkins R, Luo DD, et al. Loss of MicroRNA-192 Promotes fibrogenesis in diabetic nephropathy [J]. J Am Soc Nephrol, 2010, 21 (3): 438-447.
  • 10Han K, Chen X, Bian N, et al. Microrna profiling identifies mir-195 suppresses osteosarcoma cell metastasis by targeting ccndl [J]. Oncotarget, 2015, 6(11): 8875-8889.

二级参考文献18

  • 1Ambros V. microRNAs: tiny regulators with great potential [J]. Cell, 2001, 107:823-826.
  • 2Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116:281-297.
  • 3Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease[J]. Developmental cell, 2006, 11: 441-450.
  • 4Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors[J]. Developmental biology, 2007, 302:1-12.
  • 5Cheng Q, Yi B, Wang A, et al. Exploring and exploiting the fundamental role of microRNAs in tumor pathogenesis [J]. OncoTargets and therapy, 2013, 6:1675-1684.
  • 6Clark JC, Dass CR, Choong PF. A review of clinical and molecular prognostic factors in osteosarcoma [J]. Journal of cancer research and clinical oncology, 2008, 134:281-297.
  • 7Kansara M, Thomas DM. Molecular pathogenesis of osteosarcoma[J]. DNA and cell biology, 2007, 26:1-18.
  • 8Xia T, O'Hara A, Araujo I, et al. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3 [J]. Cancer research, 2008, 68:1436-1442.
  • 9Deng S, Calin GA, Croce CM, et al. Mechanisms of microRNA deregulation in human cancer[J]. Cell cycle (Georgetown, Tex), 2008, 7:2643-2646.
  • 10Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers[J]. Nature, 2005, 435:834-838.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部